Much of the current work to elucidate the loss of functional consequences of TREM2 variants in AD has employed the use of KO animal models and whilst a role for TREM2 has been described in microglial metabolism,8 it is not known whether disease‐relevant variants also harbor metabolic deficits or the nature of any observed deficits. Here, TREM2 is linked to Alzheimer disease.